Kastenbauer E R, von Scheel J
Laryngol Rhinol Otol (Stuttg). 1983 Dec;62(12):542-7.
The treatment of squamous cell carcinomas of the oropharynx still remains a problem because of the high rate of recurrence and the functional importance of the oropharynx in speech and swallowing. Although the technique of reconstruction after radical resection of the tumour has been considerably improved by the introduction of the pectoralis major myocutaneous flap, the need for an alternative treatment is evident in those patients with advanced tumours (T3/T4) and/or with a high risk in connection with prolonged anaesthesia and postoperative care. In some of these cases, intraarterial (i.a.) chemotherapy prior to irradiation is of increasing importance in inducing complete remission with only few side effects. Further improvement of the treatment schedules and concise application of the pharmacokinetic principles governing i.a. infusion will help to raise the prospects of curative treatment for advanced carcinoma of the oropharynx.
由于口咽鳞状细胞癌的复发率高以及口咽在言语和吞咽方面的功能重要性,其治疗仍然是一个难题。尽管通过引入胸大肌肌皮瓣,肿瘤根治性切除后的重建技术有了显著改进,但对于那些患有晚期肿瘤(T3/T4)和/或因长时间麻醉及术后护理存在高风险的患者,显然需要一种替代治疗方法。在其中一些病例中,放疗前的动脉内化疗在诱导完全缓解且副作用极少方面的重要性日益增加。进一步改进治疗方案并精确应用动脉内输注的药代动力学原理,将有助于提高晚期口咽癌的治愈前景。